Our Team

Anders has a rich background in the Life Science industry as Chairman or Board member for prominent companies such as Pelago Bioscience, Vanadis Diagnostics, Cartana, Halo Genomics, Moleculent, Genagon Therapeutics, Fenomark Diagnostics and Epigenica. His expertise extends to pivotal roles, including as Senior Advisor for Business Development at Uppsala Innovation Centre, Chief Financial Officer at Phadia AB, and Vice President Finance and Administration at Pharmacia Canada. Anders also contributes as an investor in Life Science companies through his co-owned company, Colibri Ventures.

Anders has over 35 years of work experience from conducting research in academic and pharmaceutical R&D settings. He was main responsible for driving the establishment, strategic directions and continuous development of an AstraZeneca internal unit which supported the internal R&D organisation with the type of histopathological analyses Offspring Biosciences now are offering to the wider scientific community. Anders has solid leadership and scientific skills acquired as academic research group leader and as team leader, project leader, department representative in project core teams and as member in line group management teams within the pharmaceutical industry.

Dan has over 30 years of experience working with techniques of direct relevance to our company’s service portfolio. He was main responsible for the establishment of a platform for histology-based target validation in neurology at AstraZeneca R&D, Södertälje. This included the build of a bank of animal and human tissues representing various neurological disorders as well as coordinating target validation studies from early pre-clinical phase to clinical trials in phase I. He has worked as department-representative in several drug development projects where he coordinated cross-functional activities across research and therapy areas, reporting to multiple customers and stakeholders. Dan has in-depth understanding of the drug development process in preclinical and early clinical phases and good knowledge of both small and large molecular drug pharmacology.

Anne has over 30 years of solid experience working with techniques for tissue based analyses in both academic, biotech and CRO settings, including work as Biomedical analyst at the Karolinska and at AstraZeneca R&D. Anne is one of three founders of Offspring, working as Senior Scientist, Functional project lead and Operations Manager until June 2023. She is currently a member to our Board of Director and serves as Senior advisor to our management team.

Åsa has worked in public and private sector as well as academia and has over ten years of experience in leading positions. She has over twenty years of experience working in the field of clinical microbiology and medical biochemistry and master a wide range of laboratory techniques such as e.g. proteomics, mass spectrometry, imaging, and bioinformatics. At Offspring Biosciences she is Head of Operations, responsible for HR, Finance and Operations.

Mia has over 30 years of working experience with techniques relevant to services offered by Offspring Biosciences. She has worked both in academia, pharmaceutical -, cosmetic - and biotech industry, as well as with sales and marketing in a company which targets clients in the Life Sciences sector. At Offspring Biosciences, Mia is responsible for driving continuous development of our technical capabilities and capacities needed to long term deliver value to our clients. She is also working as a functional project leader in select client projects with responsibility to coordinate execution of studies, as well as to assist the project leader with experimental design and interpretation and reporting of the results.